In the context of influenza vaccination with the trivalent influenza vaccine, we demonstrated that a minimal gene signature of nine genes associated with the serum CXCL10 level measured as soon as day1 after vaccination was able to predict specific granzyme B-producing CD8+ T cells and antibody responses 21 days later [5]. The gene discussed is CD8A; the disease is influenza.